BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3990446)

  • 1. The involvement of histamine receptors in morphine-induced increased naloxone potency in mice.
    Wong CL
    Methods Find Exp Clin Pharmacol; 1985 Feb; 7(2):69-74. PubMed ID: 3990446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The involvement of histamine H2-receptors in restraint-induced antinociception in male mice.
    Wong CL
    Methods Find Exp Clin Pharmacol; 1993; 15(6):351-6. PubMed ID: 7901462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antinociceptive effects of morphine in histamine H2 receptor gene knockout mice.
    Mobarakeh JI; Takahashi K; Sakurada S; Kuramasu A; Yanai K
    Neuropharmacology; 2006 Sep; 51(3):612-22. PubMed ID: 16806305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adrenalectomy and gonadectomy on the antinociceptive effect of morphine and naloxone antagonism in mice.
    Wong CL
    Methods Find Exp Clin Pharmacol; 1985 Oct; 7(10):529-33. PubMed ID: 4079586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the histamine system in nefopam-induced antinociception in mice.
    Girard P; Pansart Y; Coppé MC; Verniers D; Gillardin JM
    Eur J Pharmacol; 2004 Oct; 503(1-3):63-9. PubMed ID: 15496297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
    Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H1- and H2-histamine receptor blockers and opiate analgesia in mice.
    Leza JC; Lizasoain I; Lorenzo P
    Methods Find Exp Clin Pharmacol; 1990 Dec; 12(10):671-8. PubMed ID: 1983158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of morphine and nalbuphine on intestinal transit in mice.
    Wong CL
    Methods Find Exp Clin Pharmacol; 1984 Nov; 6(11):685-9. PubMed ID: 6530907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of histamine receptor antagonists on antinociceptive action of narcotic analgesics.
    Malec D
    Pol J Pharmacol Pharm; 1987; 39(3):229-35. PubMed ID: 2894018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for histamine H1 and H2 receptors in guinea-pig oxyntic cells.
    Vinik AI; Heldsinger AA; Skoglund ML
    J Pharmacol Exp Ther; 1983 Oct; 227(1):115-21. PubMed ID: 6137553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonistic action of naloxone on central histamine receptors-stimulated corticosterone secretion in rats under stress.
    Gadek-Michalska A; Bugajski J
    Agents Actions; 1989 Nov; 28(3-4):159-63. PubMed ID: 2531971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice.
    Mobarakeh JI; Takahashi K; Sakurada S; Nishino S; Watanabe H; Kato M; Naghdi N; Yanai K
    Pain; 2005 Nov; 118(1-2):254-62. PubMed ID: 16202530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the thalamic submedius nucleus histamine H1 and H 2 and opioid receptors in modulation of formalin-induced orofacial pain in rats.
    Erfanparast A; Tamaddonfard E; Taati M; Dabaghi M
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Oct; 388(10):1089-96. PubMed ID: 26077661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of morphine antinociception by swim-stress in the mouse: involvement of supraspinal opioid delta-2 receptors.
    Vanderah TW; Wild KD; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Hruby VJ; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1993 Oct; 267(1):449-55. PubMed ID: 8229774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice.
    Welch SP; Stevens DL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):10-8. PubMed ID: 1320680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of phytohaemagglutinin-induced proliferation of human peripheral blood lymphocytes by histamine and histamine H1 and H2 agonists.
    Badger AM; Young J; Poste G
    Clin Exp Immunol; 1983 Jan; 51(1):178-84. PubMed ID: 6219840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for histamine and H2-receptors in opioid antinociception.
    Gogas KR; Hough LB; Eberle NB; Lyon RA; Glick SD; Ward SJ; Young RC; Parsons ME
    J Pharmacol Exp Ther; 1989 Aug; 250(2):476-84. PubMed ID: 2547933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.